LATITUDE-TIMI 60 assessed whether losmapimod can safely reduce the risk of a subsequent cardiovascular event when started immediately after ACS.
Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical Trial
JAMA. 2016 Apr 19;315(15):1591-9.
Inhibition of p38 MAP Kinase in Patients with ST-Elevation Myocardial Infarction – Findings from the LATITUDE TIMI 60 Trial. Am Heart J. 2021 Sep 8:S0002-8703(21)00229-5. doi: 10.1016/j.ahj.2021.08.022.